383 related articles for article (PubMed ID: 24561253)
1. Small molecules enable cardiac reprogramming of mouse fibroblasts with a single factor, Oct4.
Wang H; Cao N; Spencer CI; Nie B; Ma T; Xu T; Zhang Y; Wang X; Srivastava D; Ding S
Cell Rep; 2014 Mar; 6(5):951-60. PubMed ID: 24561253
[TBL] [Abstract][Full Text] [Related]
2. Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.
Wang X; Hodgkinson CP; Lu K; Payne AJ; Pratt RE; Dzau VJ
Sci Rep; 2016 Mar; 6():23017. PubMed ID: 26975336
[TBL] [Abstract][Full Text] [Related]
3. Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.
Yuan X; Wan H; Zhao X; Zhu S; Zhou Q; Ding S
Stem Cells; 2011 Mar; 29(3):549-53. PubMed ID: 21425417
[TBL] [Abstract][Full Text] [Related]
4. Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.
Xu JY; Lee YK; Ran X; Liao SY; Yang J; Au KW; Lai WH; Esteban MA; Tse HF
Stem Cells; 2016 Nov; 34(11):2693-2706. PubMed ID: 27333945
[TBL] [Abstract][Full Text] [Related]
5. Chemical-induced cardiac reprogramming in vivo.
Huang C; Tu W; Fu Y; Wang J; Xie X
Cell Res; 2018 Jun; 28(6):686-689. PubMed ID: 29670223
[No Abstract] [Full Text] [Related]
6. Conversion of human fibroblasts into functional Leydig-like cells by small molecules and a single factor.
Zhou J; Hou Y; Zhang Z; Xing X; Zou X; Zhong L; Huang H; Zhang Z; Sun J
Biochem Biophys Res Commun; 2019 Aug; 516(1):1-7. PubMed ID: 31182281
[TBL] [Abstract][Full Text] [Related]
7. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
Hou P; Li Y; Zhang X; Liu C; Guan J; Li H; Zhao T; Ye J; Yang W; Liu K; Ge J; Xu J; Zhang Q; Zhao Y; Deng H
Science; 2013 Aug; 341(6146):651-4. PubMed ID: 23868920
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Generation of Induced Cardiomyocytes Using a Small-Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming.
Singh VP; Pinnamaneni JP; Pugazenthi A; Sanagasetti D; Mathison M; Wang K; Yang J; Rosengart TK
J Am Heart Assoc; 2020 Jun; 9(12):e015686. PubMed ID: 32500803
[TBL] [Abstract][Full Text] [Related]
9. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
[TBL] [Abstract][Full Text] [Related]
10. Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules.
Li Y; Zhang Q; Yin X; Yang W; Du Y; Hou P; Ge J; Liu C; Zhang W; Zhang X; Wu Y; Li H; Liu K; Wu C; Song Z; Zhao Y; Shi Y; Deng H
Cell Res; 2011 Jan; 21(1):196-204. PubMed ID: 20956998
[TBL] [Abstract][Full Text] [Related]
11. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.
Fu Y; Huang C; Xu X; Gu H; Ye Y; Jiang C; Qiu Z; Xie X
Cell Res; 2015 Sep; 25(9):1013-24. PubMed ID: 26292833
[TBL] [Abstract][Full Text] [Related]
12. Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes.
Wang H; Zhao S; Barton M; Rosengart T; Cooney AJ
Cell Reprogram; 2018 Feb; 20(1):27-37. PubMed ID: 29412738
[TBL] [Abstract][Full Text] [Related]
13. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds.
Shi Y; Desponts C; Do JT; Hahm HS; Schöler HR; Ding S
Cell Stem Cell; 2008 Nov; 3(5):568-74. PubMed ID: 18983970
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cardiac fibroblasts reprogramming into cardiomyocyte-like cells with a cocktail of small molecule compounds.
Chang D; Sun C; Tian X; Liu H; Jia Y; Guo Z
FEBS Open Bio; 2024 Jun; 14(6):983-1000. PubMed ID: 38693086
[TBL] [Abstract][Full Text] [Related]
15. The Future of Direct Cardiac Reprogramming: Any
López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small molecule that turns ON the pluripotency gene circuitry in human fibroblasts.
Pandian GN; Sato S; Anandhakumar C; Taniguchi J; Takashima K; Syed J; Han L; Saha A; Bando T; Nagase H; Sugiyama H
ACS Chem Biol; 2014 Dec; 9(12):2729-36. PubMed ID: 25366962
[TBL] [Abstract][Full Text] [Related]
17. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
18. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
19. And then there were none: no need for pluripotency factors to induce reprogramming.
Chou BK; Cheng L
Cell Stem Cell; 2013 Sep; 13(3):261-2. PubMed ID: 24012365
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl sulfoxide (DMSO) enhances direct cardiac reprogramming by inhibiting the bromodomain of coactivators CBP/p300.
Lim CK; Efthymios M; Tan W; Autio MI; Tiang Z; Li PY; Foo RSY
J Mol Cell Cardiol; 2021 Nov; 160():15-26. PubMed ID: 34146546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
